BioSpace News Archive

The organoids are artificial replicas of organs, which resemble cell culture quite accurately with a miniature version to study aberrant environments, advancements in technologies in the field of developmental biology.

According to the report, the global FFPE tissue samples market was valued over US$ 1.64 Bn in 2020, and it is projected to expand at a CAGR of 4.8% from 2021 to 2031.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others.

According to the report, the global cell & tissue preservation market was valued at US$ 2.95 Bn in 2020. It is projected to expand at a CAGR of 11.9% from 2021 to 2031.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per insights by Fact.MR, the global market for respiratory syncytial virus diagnostics is anticipated to grow at a CAGR of 9% over the assessment period 2021-2031, totalling US$ 1.3 by the end of 2031.

ValnevaSE, a specialty vaccine company focused on prophylactic vaccines for infectious diseases, commenced rolling submission, for initial approval of its COVID-19 vaccine candidate, VLA2001, with the Medicines and Healthcare products Regulatory Agency in the United Kingdom.

According to the report, the global acute exacerbation of CRS treatment market was valued over US$ 4.33 Bn in 2020.

Kinarus AG, a Swiss clinical-stage biopharmaceutical company announced complementary preclinical data demonstrating its lead therapeutic KIN001 could be a promising option for prevention and treatment of SARS-CoV-2 infection.

InDex Pharmaceuticals Holding AB announced that two new employees have been appointed in the clinical development organisation in preparation of the start of the phase III study CONCLUDE with cobitolimod.

Amarin Corporation plc announced that data adding to the growing body of knowledge on VASCEPA®/VAZKEPA in patients with prior heart attack, known as myocardial infarction, at risk for major adverse cardiovascular events were delivered in a Late Breaking Science Presentation at ESC Congress 2021, organized by the European Society of Cardiology, taking place virtually from August 27 – August 30, 2021.